These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 32984216

  • 1. Matrix Remodeling-Associated Protein 5 in Urinary Exosomes as a Potential Novel Marker of Obstructive Nephropathy in Children With Ureteropelvic Junction Obstruction.
    Wang Q, Shi Z, Xing X, Deng Y, Li W, Xie T, Jiang D.
    Front Pediatr; 2020; 8():504. PubMed ID: 32984216
    [Abstract] [Full Text] [Related]

  • 2. Urinary NGAL levels correlate with differential renal function in patients with ureteropelvic junction obstruction undergoing pyeloplasty.
    Cost NG, Noh PH, Devarajan P, Ivancic V, Reddy PP, Minevich E, Bennett M, Haffner C, Schulte M, DeFoor WR.
    J Urol; 2013 Oct; 190(4 Suppl):1462-7. PubMed ID: 23791906
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Changes in differential renal function after pyeloplasty in infants and children.
    Nordenström J, Koutozi G, Holmdahl G, Abrahamsson K, Sixt R, Sjöström S.
    J Pediatr Urol; 2020 Jun; 16(3):329.e1-329.e8. PubMed ID: 32146062
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pyeloplasty in children with low differential renal function: Functional recoverability.
    Sarhan O, Al Otay A, Al Faddagh A, El Helaly A, Al Hagbani M, Al Ghanbar M, Al Kawai F, Nakshabandi Z.
    J Pediatr Urol; 2021 Oct; 17(5):658.e1-658.e9. PubMed ID: 34312116
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Urinary biomarkers in hydronephrosis.
    Madsen MG.
    Dan Med J; 2013 Feb; 60(2):B4582. PubMed ID: 23461995
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Results of a practical protocol for management of prenatally detected hydronephrosis due to ureteropelvic junction obstruction.
    Karnak I, Woo LL, Shah SN, Sirajuddin A, Ross JH.
    Pediatr Surg Int; 2009 Jan; 25(1):61-7. PubMed ID: 19043723
    [Abstract] [Full Text] [Related]

  • 13. Urine levels of transforming growth factor-beta 1 in children with ureteropelvic junction obstruction.
    Palmer LS, Maizels M, Kaplan WE, Firlit CF, Cheng EY.
    Urology; 1997 Nov; 50(5):769-73. PubMed ID: 9372890
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Association between urinary biomarkers MMP-7/TIMP-2 and reduced renal function in children with ureteropelvic junction obstruction.
    Wang HS, Cho PS, Zhi H, Kostel SA, DiMartino S, Dagher AM, Davis KH, Cabour LD, Shimmel A, Lee J, Froehlich JW, Zurakowski D, Moses MA, Lee RS.
    PLoS One; 2022 Nov; 17(7):e0270018. PubMed ID: 35834547
    [Abstract] [Full Text] [Related]

  • 16. Comparison of Urinary Biomarkers in Diagnosis of Ureteropelvic Junction Obstruction and Differentiation from Nonobstructive Dilatation.
    Geminiganesan S, Kumar AR, Kumaravel S, Priya CDM, Arunaa S, Babu R.
    J Indian Assoc Pediatr Surg; 2024 Nov; 29(2):104-109. PubMed ID: 38616828
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Urinary extracellular matrix proteins as predictors of the severity of ureteropelvic junction obstruction in children.
    Mello MF, Thalita Dos Reis S, Kondo EY, de Bessa Júnior J, Dénes FT, Lopes RI.
    J Pediatr Urol; 2021 Aug; 17(4):438.e1-438.e7. PubMed ID: 33863647
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.